Advancing Innovation in Dermatology, Inc.

Taking a look back at past highlights, we're excited for this January's Dermatology Summit! Attendees will once again have the opportunity to gain invaluable insights from top industry leaders. Take a look at this clip from our successful 2024 Summit, where Frederick Beddingfield MD, PhD and Seth Orlow MD PhD share their expertise. In this segment, Dr. Orlow discusses the latest advancements in molluscum treatments. Don’t miss your chance to hear from these experts and more! #DermatologySummit #Innovation #AdvancingDerm #Dermatology Register Now For Early Bird Pricing at the Link Below https://lnkd.in/gST9Js3v

🚨 Registration is NOW OPEN! 🚨 Join us for the 12th Annual Dermatology Summit on January 12, 2025, at The Hyatt Regency San Francisco, 5 Embarcadero Center. Don't miss out on this opportunity to hear from and connect with leaders from established and emerging companies in the dermatology space. Special thanks to our Conference Board of Directors: William Ju, Seth Orlow MD PhD, Frederick Beddingfield MD, PhD, Kristen Slaoui, and Christina Weng MD. Secure your spot today and lock in early bird pricing! https://lnkd.in/gST9Js3v #DermatologySummit #AdvancingDerm #Dermatology #Innovation #SanFrancisco

📚 A Remarkable Achievement from One of Our Own Board of Trustees! 🎉 We are incredibly proud to congratulate Dr. William Eaglstein, M.D. one of our esteemed AID Trustees, on the release of his latest book, "From Vulnerable to Empowered: Transforming Your Medical Health and Doctor Experience." Dr. Eaglstein’s career has been nothing short of extraordinary—from his roles as a US Navy doctor to leading dermatology departments at prestigious universities, to his impactful work in health policy and medical research across the globe. Now, he has distilled his vast experience into a guide that empowers readers to take control of their medical journey. We are honored to have Dr. Eaglstein on our board, and his dedication to advancing medical knowledge and patient care is truly inspiring. Congratulations, Dr. Eaglstein, on this incredible accomplishment! 👏 #Healthcare #MedicalJourney #Empowerment #BookRelease #AIDLeadership 🔗: https://lnkd.in/gHWnT-rV

September 5th—Early Bird Registration Opens! The 12th Annual Dermatology Summit is set for January 12, 2025, at The Hyatt Regency San Francisco, 5 Embarcadero Center. Join financial professionals and business leaders from both seasoned and up-and-coming dermatology companies as we dive into exciting investment opportunities and forge valuable partnerships. Don’t miss this key event in the dermatology industry. Stay tuned for more details and get ready to secure your spot! 📅 Save The Date + Register for Updates 🔗:https://lnkd.in/gqPd7XAd #DermatologySummit #AdvancingDerm #InvestmentOpportunities #Networking #DermatologyIndustry

We’re thrilled to deepen our community’s knowledge on the various topics within dermatology innovation. Gaining FDA approval on treatments and drugs can be a tricky place to navigate. Thank you to our panel experts with the @FDA for sharing their insights and guidance with us in this past webinar. Access our on demand content at the link below and explore this webinar touching on: 🔬 Scientific Advances: assessment techniques for topical drugs, integrating formulation science, sparse sampling methods, spectroscopy, and physical/chemical analysis. 💊 Bioavailability/Bioequivalence: critical processes behind the approval of generic drugs, including the importance of bioavailability and bioequivalence assessments 📚 Research Involvement: Discover how you can actively participate in the FDA’s research program through the GDUFA research initiatives. 🌍 Ecosystem Impact: Understand the significant role of generic topical drugs in the broader drug ecosystem within the United States. 🔗: https://lnkd.in/eh5knMQM 👇 To view the FDA’s full presentation on the science behind innovations in topical generic drug assessment, click the link in the comments below. #Dermatology #Innovation #Research #Resources #AdvancingDerm

🚀✨ Get ready for the future of skincare at the Annual Skin & Digital Summit! Join us as Co-Founder Dominique du Crest and leading experts discuss the latest digital tech and AI innovations revolutionizing the skincare industry. From dermatology breakthroughs to aesthetic advancements, this is your chance to see the cutting-edge of our field in action. 📅 Date: 7th December 2024 💻 Format: Online Only Don't miss this opportunity to be part of the conversation that will drive the future of skin care. 🔗 Register here: https://lnkd.in/g-Bj6-xk #SkinAndDigitalSummit #Dermatology #Aesthetics #Skincare #AI #DigitalTransformation #Innovation

Celebrating our mission to the dedication to improving the lives of patients through cutting-edge research and groundbreaking treatments in dermatology, we want to shine a lot on two of our sponsors. LEO Pharma announces that the findings of phase 3 clinical trials for delgocitinib cream have been published in The Lancet. This is the first time The Lancet has published data on an investigational topical pan-Janus kinase (JAK) inhibitor for the treatment of moderate to severe chronic hand eczema. Congratulations to lead author Robert Bissonnette, MD with Innovaderm Research Inc. ! LEO Pharma’s recent success with delgocitinib cream in treating chronic hand eczema is a testament to the incredible impact that innovative treatments could have on patients' lives. By reducing the severity and symptoms of this debilitating condition, their progress is bringing hope and healing to countless individuals. The future of dermatology hinges on continued advancements in treatments and technology. With partners like LEO Pharma and Innovaderm leading the way, we are optimistic about the strides we can make together in enhancing dermatological health and access to treatments in patients’ lives. Link to LEO’s announcement here: https://lnkd.in/gAF_PwsE #Dermatology #Innovation #PatientCare #AdvancingDerm #ChronicEczema

📢 Exciting News in Dermatology! 🚀 L'Oréal, a global beauty powerhouse, acquires 10% stake in Galderma ! “We are on a journey of growth, innovation and leadership in the field of dermatology, powered by our unique integrated model. As we continue to deliver outstanding performance across our blockbuster platforms in attractive dermatology market segments, our commitment to progressing our current late-stage pipeline and advancing science and innovation remain a cornerstone of our approach. We are delighted to welcome L’Oréal as a new, long-term Galderma shareholder and see their investment as a sign of confidence in our strategy, track record and growth potential. We look forward to pursuing scientific partnership opportunities together, for the benefit of the customers, patients and consumers we serve across the globe every day.” Flemming Ornskov, MD, MPH Chief Executive Officer of Galderma Read the full announcement here: 🔗:  https://lnkd.in/dnFQPwFg #dermatology #beautyindustry #innovation #breakingnews #SkinScience

🌟 Exciting Event! 🌟 Join us for the Annual Innovations in Dermatological Sciences Conference, hosted virtually by the Rutgers Center for Dermal Research on September 24, 2024! This conference is dedicated to pushing the boundaries of topical skin products and fostering innovation in dermatological science. It brings together a diverse community of researchers, clinicians, industry professionals, and stakeholders from academia, pharmaceuticals, cosmetics, personal care, and beyond. Don't miss this opportunity to learn, exchange ideas, and explore new collaborations at the forefront of skin pharmaceutics. See you there! #Dermatology #Innovation #SkinScience #Conference2024 #RutgersDermalResearch Register Today: 🔗 https://lnkd.in/eGiC75kj

We are proud to congratulate Dr. Frederick Beddingfield MD, PhD , one of our esteemed Board Members at AID, on the exciting partnership between Gore Range Capital and SIRNAOMICS. Together they have partnered to create Sagesse Bio, advancing RNAi therapeutics for focal fat reduction and aesthetic body contouring! Dr. Beddingfield Chairman of the board at Sagesse Bio, is an internationally renowned dermatologist and a leading expert in the biopharma and aesthetics industry. He has led the development of global leading brands such as BOTOX®, JUVEDERM®, LATISSE®, and KYBELLA®. His illustrious career includes serving as Chief Medical Officer of Allergan Medical and Kythera, where he developed and gained global approvals for KYBELLA® for submental fat reduction, leading to the company's acquisition by Allergan. Additionally, he has held the role of Chief Executive Officer at Sienna Bio and Kira Pharmaceuticals. Congratulations, Dr. Beddingfield, on this remarkable achievement! We are confident that your continued efforts will lead to even more groundbreaking developments in dermatology and beyond. #Dermatology #Innovation #AdvancingDerm #BioPharma #AestheticMedicine 🔗: https://lnkd.in/g-r_t9RE